Evaluating the Therapeutic Efficacy of an Anti-BAFF Receptor Antibody Using a Rheumatoid Arthritis Mouse Model
These findings highlight the potential of BAFF-R-targeting antibodies as a therapeutic approach for RA treatment. This preclinical work lays the groundwork for future development of BAFF-R blockade as a complementary or alternative strategy to current biologic treatments.
Authors
- Itai Benhar (ORCID: https://orcid.org/0000-0002-0824-7177)
- Limor Nahary
- Adi Amir
- Adi Aharon
- Nemie Beltran
- Rachel Birnboim-Perach
- Omer Grotto
- Daniel Diadko
Institutions
- Tel Aviv University (IL)
- Wolfson Medical Center (IL)
- Israel Cancer Association (IL)
Publication Details
- Journal
- Antibodies
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3390/antib14040090
- Citations
- 1
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 1.36